Dr Philip Currie is the CEO and Founder of the CVS–CRS–CMS Group and one of Australia's most experienced cardiologists, with more than 40 years of clinical, academic and healthcare leadership experience across Australia and the United States.

After graduating from Monash University, he completed his residency and cardiology fellowship at The Alfred Hospital in Melbourne before undertaking advanced cardiology training at the Mayo Clinic in the United States. He subsequently held senior clinical and academic appointments at the Mayo Clinic, Cleveland Clinic, Michigan Heart and Vascular Institute, and Wayne State University, where he developed expertise in echocardiography, cardiovascular imaging, valvular heart disease, structural heart disease and adult congenital heart disease.

Returning to Australia in 1997, Dr Currie established what has evolved into one of Australia's most innovative integrated healthcare organisations. Beginning with Cardio Vascular Services (CVS), the Group expanded to include Cardio Respiratory Sleep (CRS) and Cardio Metabolic Services (CMS), reflecting his long-standing vision that patients should be managed as whole individuals rather than through fragmented specialty care. Through the integration of cardiovascular, respiratory, sleep and metabolic medicine, the Group has developed a coordinated model of care focused on prevention, early detection and long-term health outcomes, with services now operating across Western Australia and Victoria.

Today, CVS–CRS–CMS provides comprehensive services spanning cardiology, vascular medicine, respiratory medicine, sleep medicine, obesity and weight management, lipid disorders, metabolic health, liver disease, cognitive health, psychology, dietetics, exercise physiology and preventive medicine. The organisation is recognised for its multidisciplinary approach to addressing the growing burden of cardiometabolic disease and chronic illness through integrated, patient-centred care. Dr Currie is also a founding director of Integra Trials, a specialist Phase II–IV clinical trials organisation that connects patients with emerging therapies and supports research across cardiovascular disease, metabolic health, liver disease, respiratory medicine, neurology, healthy ageing and longevity.

His current focus is the development of integrated models of care that promote health across the entire lifespan. From fertility and reproductive health through midlife metabolic and cardiovascular optimisation, and ultimately to longevity, cognitive wellbeing and healthy ageing, Dr Currie continues to lead the evolution of healthcare towards a more integrated, preventive, and person-centred model. Through the CVS–CRS–CMS Group and Integra Trials, he is helping bridge the gaps between specialist disciplines, research, prevention and wellness to deliver better outcomes for patients and communities.

His vision remains clear: not simply to treat disease, but to preserve health, extend healthspan and improve quality of life through coordinated, patient-centred care spanning every stage of life—from childhood and reproductive health to healthy ageing and longevity.